CXCR5 and melanoma: Although CXCR5 is not included in all analyses, the identified subsets display increased T‐cell functionality within tumor infiltrating lymphocytes, and PD‐1+Tcf1+ CD8 T cells are positively correlated with survival and clinical response to PD‐1 ICB in melanoma [19, 20, 21, 23, 24].